l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function

In order to assess the role of striatal dopamine (DA) afferents in l-DOPA-induced dyskinesia, we have studied a large series of rats sustaining 2, 3, or 4 unilateral injections of 6-hydroxydopamine (6-OHDA) in the lateral striatum. This type of lesion produced a dose-dependent depletion of DA fibers...

Full description

Bibliographic Details
Main Authors: Christian Winkler, Deniz Kirik, Anders Björklund, M.Angela Cenci
Format: Article
Language:English
Published: Elsevier 2002-07-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996102904997
id doaj-634622cc0ff14b62a41f3dbb4e043489
record_format Article
spelling doaj-634622cc0ff14b62a41f3dbb4e0434892021-03-20T04:47:51ZengElsevierNeurobiology of Disease1095-953X2002-07-01102165186l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal FunctionChristian Winkler0Deniz Kirik1Anders Björklund2M.Angela Cenci3Department of Physiological Sciences, Neurobiology Division, Wallenberg Neuroscience Center, Lund University, BMC A11, S-221 84, Lund, Sweden; Department of Neurology, Hannover Medical School, D-30625, Hannover, GermanyDepartment of Physiological Sciences, Neurobiology Division, Wallenberg Neuroscience Center, Lund University, BMC A11, S-221 84, Lund, Sweden; Department of Neurology, Hannover Medical School, D-30625, Hannover, GermanyDepartment of Physiological Sciences, Neurobiology Division, Wallenberg Neuroscience Center, Lund University, BMC A11, S-221 84, Lund, Sweden; Department of Neurology, Hannover Medical School, D-30625, Hannover, GermanyDepartment of Physiological Sciences, Neurobiology Division, Wallenberg Neuroscience Center, Lund University, BMC A11, S-221 84, Lund, Sweden; Department of Neurology, Hannover Medical School, D-30625, Hannover, GermanyIn order to assess the role of striatal dopamine (DA) afferents in l-DOPA-induced dyskinesia, we have studied a large series of rats sustaining 2, 3, or 4 unilateral injections of 6-hydroxydopamine (6-OHDA) in the lateral striatum. This type of lesion produced a dose-dependent depletion of DA fibers in the caudate-putamen, which was most pronounced in the lateral aspects of this structure. An additional group of rats was injected with 6-OHDA in the medial forebrain bundle to obtain complete DA denervation on one side of the brain. During a course of chronic l-DOPA treatment, rats with intrastriatal 6-OHDA lesions developed abnormal involuntary movements (AIMs), which mapped onto striatal domains exhibiting at least ∼90% denervation, as judged by DA transporter autoradiography. The denervated areas showed local upregulation of preproenkephalin and prodynorphin mRNA, and FosB-like immunoreactivity, which were highly correlated with the rats' AIM scores. When compared to completely DA-denervated animals, the rats with intrastriatal 6-OHDA lesions showed an overall lower incidence, lower severity and different topographic distribution of AIMs. The involvement of proximal limb and axial muscles in the abnormal movements was proportional to the spreading of the lesion from lateral towards medial aspects of the caudate-putamen. Locomotive AIMs were only seen in rats with complete lesions, but not in any of the animals with intrastriatal 6-OHDA (which showed > 5% DA fiber sparing in the medial striatum). Intrastriatally 6-OHDA-lesioned rats had a larger therapeutic window for l-DOPA than did rats with complete bundle lesions, since they exhibited an overall lower predisposition to dyskinesia but a similar degree of drug-induced motor improvement in a test of forelimb stepping. Our results are the first to demonstrate that selective and partial DA denervation in the sensorimotor part of the striatum can confer cellular and behavioral supersensitivity to l-DOPA, and that the phenomenology of l-DOPA-induced rat AIMs can be accounted for by the topography of DA denervation within the caudate-putamen.http://www.sciencedirect.com/science/article/pii/S0969996102904997basal gangliabehaviourenkephalindynorphindelta-fosBsensitization
collection DOAJ
language English
format Article
sources DOAJ
author Christian Winkler
Deniz Kirik
Anders Björklund
M.Angela Cenci
spellingShingle Christian Winkler
Deniz Kirik
Anders Björklund
M.Angela Cenci
l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
Neurobiology of Disease
basal ganglia
behaviour
enkephalin
dynorphin
delta-fosB
sensitization
author_facet Christian Winkler
Deniz Kirik
Anders Björklund
M.Angela Cenci
author_sort Christian Winkler
title l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
title_short l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
title_full l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
title_fullStr l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
title_full_unstemmed l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
title_sort l-dopa-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2002-07-01
description In order to assess the role of striatal dopamine (DA) afferents in l-DOPA-induced dyskinesia, we have studied a large series of rats sustaining 2, 3, or 4 unilateral injections of 6-hydroxydopamine (6-OHDA) in the lateral striatum. This type of lesion produced a dose-dependent depletion of DA fibers in the caudate-putamen, which was most pronounced in the lateral aspects of this structure. An additional group of rats was injected with 6-OHDA in the medial forebrain bundle to obtain complete DA denervation on one side of the brain. During a course of chronic l-DOPA treatment, rats with intrastriatal 6-OHDA lesions developed abnormal involuntary movements (AIMs), which mapped onto striatal domains exhibiting at least ∼90% denervation, as judged by DA transporter autoradiography. The denervated areas showed local upregulation of preproenkephalin and prodynorphin mRNA, and FosB-like immunoreactivity, which were highly correlated with the rats' AIM scores. When compared to completely DA-denervated animals, the rats with intrastriatal 6-OHDA lesions showed an overall lower incidence, lower severity and different topographic distribution of AIMs. The involvement of proximal limb and axial muscles in the abnormal movements was proportional to the spreading of the lesion from lateral towards medial aspects of the caudate-putamen. Locomotive AIMs were only seen in rats with complete lesions, but not in any of the animals with intrastriatal 6-OHDA (which showed > 5% DA fiber sparing in the medial striatum). Intrastriatally 6-OHDA-lesioned rats had a larger therapeutic window for l-DOPA than did rats with complete bundle lesions, since they exhibited an overall lower predisposition to dyskinesia but a similar degree of drug-induced motor improvement in a test of forelimb stepping. Our results are the first to demonstrate that selective and partial DA denervation in the sensorimotor part of the striatum can confer cellular and behavioral supersensitivity to l-DOPA, and that the phenomenology of l-DOPA-induced rat AIMs can be accounted for by the topography of DA denervation within the caudate-putamen.
topic basal ganglia
behaviour
enkephalin
dynorphin
delta-fosB
sensitization
url http://www.sciencedirect.com/science/article/pii/S0969996102904997
work_keys_str_mv AT christianwinkler ldopainduceddyskinesiaintheintrastriatal6hydroxydopaminemodelofparkinsonsdiseaserelationtomotorandcellularparametersofnigrostriatalfunction
AT denizkirik ldopainduceddyskinesiaintheintrastriatal6hydroxydopaminemodelofparkinsonsdiseaserelationtomotorandcellularparametersofnigrostriatalfunction
AT andersbjorklund ldopainduceddyskinesiaintheintrastriatal6hydroxydopaminemodelofparkinsonsdiseaserelationtomotorandcellularparametersofnigrostriatalfunction
AT mangelacenci ldopainduceddyskinesiaintheintrastriatal6hydroxydopaminemodelofparkinsonsdiseaserelationtomotorandcellularparametersofnigrostriatalfunction
_version_ 1724212123987345408